Aridica builds laboratory automation tools that isolate immune cells with higher consistency, reliability, and quality while reducing hands‑on time and waste. Their fully automated workflow—featuring low‑cost instruments and consumables such as the Thawsome Cryotube Adapters—standardizes sample handling, enabling scalable deployment across sites for discovery, monitoring, and therapeutic research. This automation improves reproducibility for single‑cell genomics, high‑dimensional cytometry, and biomarker diagnostics.
Funding
Funding not disclosed
Founders
Product
Problem
Manual immune‑cell isolation workflows rely on extensive pipetting and operator expertise, leading to high variability, sample loss, and limited reproducibility across laboratories and over time.
Solution
Aridica offers fully automated cryotube adapters and accompanying laboratory automation tools that standardize the isolation of immune cells. The system performs the entire workflow with minimal hands‑on handling, reducing operator‑induced variation and improving the reliability of each sample. Low‑cost instrumentation and consumables enable deployment in multiple sites without specialized training, while the automated process cuts plastic waste and shortens preparation time. Consistently high‑quality cell isolates support downstream applications such as single‑cell genomics, high‑dimensional cytometry, biomarker monitoring, and immune‑cell therapy development.
Target Audience
Primary customers are academic research labs, biotech and pharmaceutical R&D groups, and clinical laboratories that require reproducible immune‑cell isolation for discovery, diagnostic monitoring, or therapeutic development.
Features
- Stand‑alone cryotube adapters that automate cell‑isolation steps without manual pipetting
- Integrated workflow control software that standardizes protocols across operators and sites
- Low‑cost hardware and disposable consumables designed for easy scaling in multi‑site environments
- Minimal sample handling to reduce loss and improve cell viability for high‑resolution assays
- Reduced plastic waste through automated pipette‑free processing, lowering disposal costs
- Compatibility with downstream platforms for single‑cell sequencing, cytometry, diagnostics, and cell‑therapy pipelines